BCHE and myasthenia gravis: Approximately 21% of patients do not respond to conventional treatment or present some form of intolerance, resulting in refractory myasthenia gravis (refractory MG), a condition defined by persistent clinical symptoms or exacerbations despite adequate use of standard therapies, such as cholinesterase inhibitors, corticosteroids, and at least one immunosuppressive agent [30].